Sight Sciences (SGHT) EBIT Growth (3y) (2023 - 2026)
Sight Sciences (SGHT) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 13.06% |
| 10 | Sight Sciences | 443.40 Mn | 363.65 Mn | 21.37 Mn | 36.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.50% |
| Mar 31, 2026 | 10.93% |
| Dec 31, 2025 | 40.08% |
| Sep 30, 2025 | 28.74% |
| Jun 30, 2025 | 20.09% |
| Mar 31, 2025 | 14.53% |
| Dec 31, 2024 | 6.76% |
| Sep 30, 2024 | 7.15% |
| Jun 30, 2024 | -4.53% |
| Mar 31, 2024 | -8.10% |
| Dec 31, 2023 | -9.63% |
| Sep 30, 2023 | -22.17% |
| Jun 30, 2023 | -25.46% |